兰州大学机构库
A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
2022-03-28
Source PublicationFRONTIERS IN PHARMACOLOGY   Impact Factor & Quartile
EISSN1663-9812
Volume13
page numbers22
AbstractBackground: For anaphylaxis, a life-threatening allergic reaction, the incidence rate was presented to have increased from the beginning of the 21st century. Underdiagnosis and undertreatment of anaphylaxis are public health concerns.Objective: This guideline aimed to provide high-quality and evidence-based recommendations for the emergency management of anaphylaxis.Method: The panel of health professionals from fifteen medical areas selected twenty-five clinical questions and formulated the recommendations with the supervision of four methodologists. We collected evidence by conducting systematic literature retrieval and using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach.Results: This guideline made twenty-five recommendations that covered the diagnosis, preparation, emergency treatment, and post-emergency management of anaphylaxis. We recommended the use of a set of adapted diagnostic criteria from the American National Institute of Allergy and Infectious Diseases and the Food Allergy and Anaphylaxis Network (NIAID/FAAN), and developed a severity grading system that classified anaphylaxis into four grades. We recommended epinephrine as the first-line treatment, with specific doses and routes of administration for different severity of anaphylaxis or different conditions. Proper dosage is critical in the administration of epinephrine, and the monitor is important in the IV administration. Though there was only very low or low-quality evidence supported the use of glucocorticoids and H1 antagonists, we still weakly recommended them as second-line medications. We could not make a well-directed recommendation regarding premedication for preventing anaphylaxis since it is difficult to weigh the concerns and potential effects.Conclusion: For the emergency management of anaphylaxis we conclude that:center dot NIAID/FAAN diagnostic criteria and the four-tier grading system should be used for the diagnosis center dot Prompt and proper administration of epinephrine is critical.
Keywordanaphylaxis clinical practice guideline epinephrine emergency management severity grading system
PublisherFRONTIERS MEDIA SA
DOI10.3389/fphar.2022.845689
Indexed BySCIE
Language英语
WOS Research AreaPharmacology & Pharmacy
WOS SubjectPharmacology & Pharmacy
WOS IDWOS:000787071700001
Original Document TypeReview
PMID 35418863
Citation statistics
Cited Times:7[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttps://ir.lzu.edu.cn/handle/262010/481076
Collection兰州大学
基础医学院
Corresponding AuthorWang, Qiang; Zhai, Suodi
Affiliation
1.Peking Univ Third Hosp, Dept Pharm, Beijing, Peoples R China;
2.Peking Univ, Sch Pharmaceut Sci, Beijing, Peoples R China;
3.Peking Univ, Hlth Sci Ctr, Inst Drug Evaluat, Beijing, Peoples R China;
4.Peking Univ Third Hosp, Emergency Dept, Beijing, Peoples R China;
5.Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Allergy, Beijing, Peoples R China;
6.Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, State Key Lab Resp Dis, Guangzhou, Peoples R China;
7.Shandong Univ, Qilu Hosp, Inst Emergency & Crit Care Med, Dept Emergency Med, Jinan, Peoples R China;
8.Shandong Univ, Qilu Hosp, Inst Emergency & Crit Care Med, Chest Pain Ctr, Jinan, Peoples R China;
9.Capital Med Univ, Beijing Shijitan Hosp, Dept Anesthesiol, Beijing, Peoples R China;
10.Capital Med Univ, Xuanwu Hosp, Pharm Dept, Beijing, Peoples R China;
11.Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Peoples R China;
12.Peking Univ Third Hosp, Dept Nursing, Beijing, Peoples R China;
13.Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Coronary Heart Dis Ctr, Dept Internal Med, Beijing, Peoples R China;
14.Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol & Perioperat Med, Xian, Peoples R China;
15.Capital Inst Pediat, Childrens Hosp, Dept Otolaryngol, Beijing, Peoples R China;
16.Chinese PL Gen Hosp, Pharm Dept, Beijing, Peoples R China;
17.Fourth Mil Med Univ, Xijing Hosp, Dept Nursing, Xian, Peoples R China;
18.Chinese Peoples Liberat Army Gen Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China;
19.Peking Univ Peoples Hosp, Dept Pharm, Beijing, Peoples R China;
20.Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Peoples R China;
21.Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Anesthesiol, Shanghai, Peoples R China;
22.Renmin Univ China, Sch Publ Adm & Policy, Beijing, Peoples R China;
23.Renmin Univ China, Hlth Technol Assessment & Hlth Policy Res Grp, Beijing, Peoples R China;
24.Shenzhen Baoan Pure Chinese Med Treatment Hosp, Dept Pharm, Shenzhen, Peoples R China;
25.Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Pediat, Shanghai, Peoples R China;
26.Gen Hosp Cent Theater Command PLA, Dept Clin Pharmacol, Wuhan, Peoples R China;
27.Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai, Peoples R China;
28.Shanxi Med Univ, Hosp 1, Dept Nursing, Taiyuan, Peoples R China;
29.Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Pharm, Shanghai, Peoples R China;
30.Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Nanjing, Peoples R China;
31.Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China;
32.Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin, Peoples R China;
33.Peking Univ, Sch Publ Hlth, Hlth Sci Ctr, Dept Epidemiol & Biostat, Beijing, Peoples R China;
34.China Japan Friendship Hosp, Dept Emergency, Beijing, Peoples R China;
35.Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pharm, Beijing, Peoples R China;
36.Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin, Peoples R China;
37.Peking Univ Third Hosp, Dept Anesthesiol, Beijing, Peoples R China;
38.Natl Hlth Commiss Peoples Republ China, Natl Ctr Med Serv Adm, Beijing, Peoples R China;
39.Oklahoma Univ, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA
Recommended Citation
GB/T 7714
Li, Xiaotong,Ma, Qingbian,Yin, Jia,et al. A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)[J]. FRONTIERS IN PHARMACOLOGY,2022,13.
APA Li, Xiaotong.,Ma, Qingbian.,Yin, Jia.,Zheng, Ya'an.,Chen, Rongchang.,...&Zhai, Suodi.(2022).A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020).FRONTIERS IN PHARMACOLOGY,13.
MLA Li, Xiaotong,et al."A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)".FRONTIERS IN PHARMACOLOGY 13(2022).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Li, Xiaotong]'s Articles
[Ma, Qingbian]'s Articles
[Yin, Jia]'s Articles
Baidu academic
Similar articles in Baidu academic
[Li, Xiaotong]'s Articles
[Ma, Qingbian]'s Articles
[Yin, Jia]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Li, Xiaotong]'s Articles
[Ma, Qingbian]'s Articles
[Yin, Jia]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.